Skip to main content
Tarek Elrafei, DO, Oncology, Bronx, NY, NYC Health + Hospitals / Jacobi

TarekElrafeiDO

Oncology Bronx, NY

Breast Cancer, Cancer Genetics/Cancer Risk Assessment, Hematologic Oncology

Associate Professor, Medicine, A Einstein College of Medicine of Yeshiva Univ

Dr. Elrafei is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Elrafei's full profile

Already have an account?

Summary

  • Dr. Tarek Elrafei is an oncologist in Bronx, NY and is affiliated with multiple hospitals in the area, including NYC Health + Hospitals / Jacobi and Montefiore Medical Center. He received his medical degree from Nova Southeastern University - College of Osteopathic Medicine and has been in practice 22 years. He specializes in breast cancer, cancer genetics/cancer risk assessment, and hematologic oncology and is experienced in hematologic oncology, hematology, and medical oncology.

Education & Training

  • Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)
    Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Hematology and Medical Oncology, 2000 - 2003
  • Icahn School of Medicine at Mount Sinai (Beth Israel)
    Icahn School of Medicine at Mount Sinai (Beth Israel)Residency, Internal Medicine, 1996 - 1999
  • Nova Southeastern University College of Osteopathic Medicine
    Nova Southeastern University College of Osteopathic MedicineClass of 1995
  • Rutgers University
    Rutgers UniversityB.S., 1987 - 1991

Certifications & Licensure

  • NY State Medical License
    NY State License 1998 - 2026
  • NJ State Medical License
    NJ State License 2000 - 2025
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Journal Articles

  • Using a Patient Navigation Program to Overcome Health Care Disparities in Cancer Treatment in a Multicultural Setting  
    Tarek Elrafei, Maria Castaldi, Marianna Strakhan, Karenza Alexis, Louis Juden Reed, Bassam Shaker, Tina Stanise, Mariaelena Marquez, Richard J. Gralla, Supportive Care in Cancer, International MASCC/ISOO Symposium, 6/27/2013
  • A multicenter phase I study of intravenous administration of reolysin in combination with irinotecan/fluorouracil/leucovorin (FOLFIRI) in patients with oxaplatin-refra...  
    Allyson J. Ocean, Tanios S. Bekaii-Saab, Imran Chaudhary, Romae Palmer, Paul J. Christos, Alice Mercado, Erika O. Florendo, Veronica A. Rosales, Joseph T. Ruggiero, El..., Journal of Clinical Oncology, 1/1/2012
  • Dermatofibrosarcoma protuberans-derived fibrosarcoma: Response to escalated dose imatinib mesylate (IM) and second generation kinase-inhibitor nilotinib  
    T.N. Elrafei, G Chrysofakis, N Simmons, L.J. Reed, Journal of Clinical Oncology, 5/1/2011
  • Join now to see all

Abstracts/Posters

  • Can patient navigation help overcome barriers to breast cancer treatment in patients with health care disparities?
    Tarek N. Elrafei, Maria Castaldi, Bassam Shaker, Tina Stanise, Richard J. Gralla, Mariaelena Marquez, William Bodner, Louis Juden Reed, Marianna Strakhan, Karenza M. A..., San Antonio Breast Cancer Symposium, San Antonio, TX, 12/11/2013
  • Overcoming health care disparities in cancer treatment by instituting a patient navigation program
    Tarek N. Elrafei, Maria Castaldi, Bassam Shaker, Tina Stanise, Mariaelena Marquez, William Bodner, Louis Juden Reed, Karenza M. Alexis, Marianna Strakhan, Richard J. G..., Journal of Clinical Oncology, 1/31/2013
  • Dermatofibrosarcoma protuberans: Preoperative therapy with imatinib mesylate and use of plasma PDGF-B levels to monitor clinical response
    M. Macapinlac, T. Elrafei, I. Cunningham, M. Horowitz, F. Paracha, R. Mbaoma, D. Jayabalan, S. Mani, Proceedings of American Society of Clinical Oncology, 6/1/2004
  • Join now to see all

Hospital Affiliations